Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary biliary cirrhosis].

R Poupon1

  • 1Unité d'hépatologie et de gastroentérologie, hôpital Saint-Antoine, Paris.

La Revue Du Praticien
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Primary biliary cirrhosis is a chronic liver disease affecting middle-aged women, characterized by bile duct inflammation and destruction. Treatments like ursodeoxycholic acid and liver transplantation have improved patient prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.

Clinics and research in hepatology and gastroenterology·2012
Same author

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.

Journal of viral hepatitis·2012
Same author

Pruritus in liver disease: introductory remarks.

Clinics and research in hepatology and gastroenterology·2011
Same author

Ursodeoxycholic acid and chemoprevention of colorectal cancer.

Gastroenterologie clinique et biologique·2010
Same author

Bile secretion.

Gastroenterologie clinique et biologique·2010
Same author

The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults.

Gastroenterologie clinique et biologique·2010
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Context:

  • Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease.
  • It primarily affects middle-aged women.
  • Characterized by portal inflammation and destruction of small intrahepatic bile ducts.

Purpose:

  • To describe the epidemiology, pathogenesis, clinical presentation, and management of PBC.
  • To highlight advancements in PBC treatment and prognosis.

Summary:

  • PBC prevalence is 8-12 cases per 100,000 population.
  • Etiology may involve genetic, infectious, and immunological factors.
  • Disease progression includes cholestasis, fibrosis, cirrhosis, and potential complications like ascites and portal hypertension.

Related Experiment Videos

Impact:

  • Early diagnosis is facilitated by antimitochondrial antibodies or elevated liver enzymes.
  • Clinical phases range from asymptomatic to symptomatic with liver damage, and terminal stages with severe cholestasis.
  • Liver transplantation and ursodeoxycholic acid have significantly improved PBC prognosis.